Short Communication Open Access
Volume 2 | Issue 4 | DOI: https://doi.org/10.33696/haematology.2.039
Deep Immune Status Monitoring with Multi-color Flow Cytometry
Weiwei Wang1, Guang Fan2,*, Lisong Shen1
- 1Department of Clinical laboratory, Xinhua hospital, Shanghai Jiaotong University of Medicine School, Shanghai, China
- 2Department of Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR, USA
Corresponding Author
Guang Fan, fang@ohsu.edu
Received Date: August 28, 2021
Accepted Date: September 29, 2021
Wang W, Fan G, Shen L. Deep Immune Status Monitoring with Multi-Color Flow Cytometry. J Clin Haematol. 2021; 2(4):115-116.
Copyright: © 2021 Wang W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
Although NK cells are recognized as effector lymphocytes of the innate immune system, they also regulate the adaptive immune response by releasing inflammatory cytokines and developing immunological memory. Unlike other lymphocytes such as T or B cells, NK cells do not express rearrangeable, antigen-specific receptors.
Deubiquitinase as Potential Targets for Cancer Immunotherapy
During the last few decades, immunotherapy is considered to be an important approach to help our immune system to fight various kinds of diseases, such as tumor. Sometimes, it works very well for some types of cancers, for example: bladder cancer, colorectal cancer, breast cancer and lymphoma.
The Role of Direct Oral Anticoagulants in Advanced Chronic Kidney Disease – Questions and Future directions
With the advent of the direct oral anticoagulants (DOACs), patients requiring anticoagulation for common conditions such as atrial fibrillation and venous thromboembolism no longer need to worry about dietary restrictions or regular monitoring of the international normalized ratio which complicated warfarin treatment.
Role of the Gut Microbiome in the Modulation of Cancer Immunotherapy Response
The gut microbiome or gut flora is a vast community of microorganisms such as bacteria, viruses, protozoa, and fungi that inhabit the digestive tract of the human and other animals [1,2]. In the human body, bacterial species colonize into the oral cavity, skin, vagina, and placenta, however, the largest population of microorganisms resides in the intestine.
CTLA-4 and PD-L1 or PD-1 Pathways: Immune Checkpoint Inhibitors and Cancer Immunotherapy
The immune system developed certain checks and balance to control or inhibit the reactivity against normal cells of the body. Uncontrolled immune responses to the non-self entities such as bacteria, viruses, parasites, or mutated self-antigens can cause an inflammatory reaction and autoimmune diseases.